Adherence to self-administered biologic disease-modifying antirheumatic drugs across health-system specialty pharmacies

by Canfield, S., Carter, J., Choi, L., Cowgill, N., Declercq, J., Dura, J., Gazda, N.P, Gerzenshtein, L., Kehasse, A., Lach, M., Lee, J., Lewis, K., Lounsbery, B., Mccarthy, K., Ortega, M., Shah, R., Sokos, L., Stutsky, M., Thomas, K.C, Thomas, T.T, Wise, K., Young, J., Zuckerman, A.D
Published 2021

Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis

by Carter, J.A, Diakite, I., Schultz, B.G, Snedecor, S.J, Turpin, R.
Published 2021

Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study

by Desai, R.J, Khosrow-Khavar, F., Kim, S.C, Pawar, A., Weinblatt, M.E
Published 2022

A questionnaire-based survey on depression and anxiety among rheumatology patients during the covid-19 pandemic: Patient’s perspective

by Baharuddin, H., Bhullar, A., Ch’ng, S.S, Lim, S.L, Rosman, A., Tay, V.Y, Yusoof, H.M, Zain, M.M
Published 2021